Golden G S
Child Development Center; University of Tennessee Center for the Health Sciences, Memphis 38105.
Pediatr Neurol. 1985 May-Jun;1(3):192-4. doi: 10.1016/0887-8994(85)90063-3.
Three patients are reported who developed oral-buccal-lingual movements typical of tardive dyskinesia while being treated with stable doses of haloperidol for Tourette syndrome. In each case signs resolved within a number of weeks after medication was discontinued. One of the patients experienced recurrence of the dyskinesia during a challenge with phenothiazine tranquilizers. In each case the dose of haloperidol was well within the usual therapeutic range. A strong family history of movement disorders, including Tourette syndrome, was present in each family.